PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2410877-1	1985	A 66-year-old female with chronic renal failure received five doses of procainamide and developed marked QT interval prolongation and recurrent episodes of torsades de pointes, which were temporally related to high serum n-acetylprocainamide (NAPA) levels and not to procainamide levels.	Procainamide	71-83	NSF attachment protein alpha	Homo sapiens	243-247	
2410877-1	1985	A 66-year-old female with chronic renal failure received five doses of procainamide and developed marked QT interval prolongation and recurrent episodes of torsades de pointes, which were temporally related to high serum n-acetylprocainamide (NAPA) levels and not to procainamide levels.	Acecainide	221-241	NSF attachment protein alpha	Homo sapiens	243-247	
2410877-3	1985	Torsades de pointes is a potential hazard of NAPA accumulation during procainamide administration to patients with renal insufficiency.	Procainamide	70-82	NSF attachment protein alpha	Homo sapiens	45-49